Eli Lilly is partnering with OpenAI to help research antimicrobial resistance (AMR) treatments. Research suggests that AI in the healthcare market could be a $187 billion opportunity by 2030.
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. Just look at Eli Lilly (NYSE: LLY ).
Healthcare stocks to buy have been off to the races recently — especially the ones in the weight-loss drug market. Indeed, the market is huge and could entail considerable growth for many years into
This has been a very good year for the stock market as a whole, although the performance of broad U.S. indexes also underscores how important the weighting of an index can be.
Weight loss drugs have taken the pharmaceutical and medical communities by storm. Not only are the companies behind the medications struggling to keep up with global demand, but reports are emerging t

Stock Split Watch: Is Eli Lilly Next?

04:35am, Friday, 28'th Jun 2024
Eli Lilly's shares have soared more than 50% this year to about $900. This level may discourage some investors from hitting the buy button.

Stock Split Watch: Is Eli Lilly Next?

04:35am, Friday, 28'th Jun 2024
Eli Lilly's shares have soared more than 50% this year to about $900. This level may discourage some investors from hitting the buy button.

3 Biotech Stocks For The Second Half Of 2024

04:48pm, Thursday, 27'th Jun 2024
3 Biotech Stocks For The Second Half Of 2024
Biotech stocks to buy now reflect a more dynamic shift in investor focus of late.Over the past few years, the biotech space attracted plenty of investor interest, driven by the Covid-19 pandemic. Glob
Louise Chen, Cantor Fitzgerald analyst, joins CNBC's 'Squawk Box' to discuss Eli Lilly's surge over the past year, manufacturing, and more.
The notion that an investor can turn $10,000 into $1 million without a very long investment period will certainly raise a lot of eyebrows. However, many high-growth stocks have turned a $10,000 invest
The Nasdaq and S&P 500 are steadily growing as tech companies lift the market. The past few months have been excellent for investors, with several stocks hitting new 52-week highs.
In the most recent trading session, Eli Lilly (LLY) closed at $901.26, indicating a -0.37% shift from the previous trading day.
Novo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as their approval in China. While these names
Drugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant for doctors.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE